surpris miss lower guidanc still believ buyer
morn report fiscal result miss expect top
line ep essenti in-lin revenu guidanc also expect
primari caus shortfal weak compani protect pci busi
neg impact fda cautionari letter clinician impella rp
caus confus among physician manag note busi improv
bit april believ total compel clinic data improv util
patient popul go forward today disclosur certainli surpris
alter view util impella new product develop
larg address market compet today futur consequ
encourag investor buy dip reiter overweight rate although lower
pt given reduc top-line growth outlook
fiscal result report fiscal revenu fell short expect
sale short bogey primari sourc
shortfal domest impella revenu came roughli
target grew toughest comp year
gross margin essenti line target adjust ep
also top estim
guidanc expect top shortfal fourth quarter
manag also provid guidanc expect compani call
top-lin growth rang compar street closer
high manag also state either reaffirm alter guidanc
rang end fiscal biggest part softer outlook protect
pci portion busi saw slowdown fda letter right side
point call obvious shortfal quarter softer-than-
expect guidanc key item call compani protect pci
neg impact cautionari letter impella rp clinician question
whether warn appli left side devic well mention
seen uptick part busi april follow posit data releas
believ perform improv determin happen
segment busi difficult miss
believ strength clinic data win end anticip growth
improv outlook perspect specul
believ growth profil busi find low water mark either
stay level acceler go forward combin low penetr rate
domest intern growth drive sale
develop manufactur circulatori support devic
ev/ci sale
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
stock result guidanc clearli startl stock like
reflect throughout cours day said continu believ growth outlook
busi remain strong medic devic compani public
market consequ defend name reiter ow rate though
lower pt multipl revenu assum net cash
s/o given reduc top-line growth outlook multipl previous base
sourc compani report piper jaffray co estim
page
good gener incom expens net incom net incom analysi gross gener analysisu impella impella
thousand except per share data
good sold
good sold
percent sale
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
